Philadelphia negative myeloproliferative neoplasms (MPN) typically carry a driver mutation in the genes for janus kinase (JAK) 2, in calreticulin (CALR) or in the thrombopoietin receptor (MPL). The gene discussed is MPL; the disease is neoplasm.